Elanco Animal Health (ELAN)
(Delayed Data from NYSE)
$14.07 USD
-1.00 (-6.64%)
Updated Sep 20, 2024 04:00 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for Elanco Animal Health Incorporated falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 352 | 345 | 638 | 505 | 345 |
Receivables | 1,010 | 1,002 | 1,028 | 1,077 | 890 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,735 | 1,538 | 1,373 | 1,578 | 1,051 |
Other Current Assets | 310 | 394 | 237 | 256 | 87 |
Total Current Assets | 3,407 | 3,279 | 3,276 | 3,417 | 2,373 |
Net Property & Equipment | 1,026 | 999 | 1,061 | 1,316 | 955 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 9,588 | 10,835 | 11,759 | 12,612 | 5,472 |
Deposits & Other Assets | 341 | 378 | 387 | 348 | 185 |
Total Assets | 14,362 | 15,491 | 16,483 | 17,693 | 8,986 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 270 | 390 | 418 | 501 | 223 |
Current Portion Long-Term Debt | 38 | 388 | 294 | 555 | 25 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 933 | 924 | 931 | 1,021 | 571 |
Total Current Liabilities | 1,241 | 1,702 | 1,643 | 2,076 | 819 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 567 | 662 | 745 | 900 | 101 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 5,736 | 5,448 | 6,025 | 5,572 | 2,331 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 595 | 390 | 532 | 668 | 189 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 8,139 | 8,202 | 8,945 | 9,217 | 3,439 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 8,777 | 8,738 | 8,696 | 8,650 | 5,636 |
Retained Earnings | -2,288 | -1,057 | -949 | -477 | 84 |
Other Equity | -266 | -392 | -209 | 303 | -174 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 6,223 | 7,289 | 7,538 | 8,476 | 5,547 |
Total Liabilities & Shareholder's Equity | 14,362 | 15,491 | 16,483 | 17,693 | 8,986 |
Total Common Equity | 6,223 | 7,289 | 7,538 | 8,476 | 5,547 |
Shares Outstanding | 492.80 | 474.20 | 473.10 | 471.90 | 373.00 |
Book Value Per Share | 12.63 | 15.37 | 15.93 | 17.96 | 14.87 |
Fiscal Year End for Elanco Animal Health Incorporated falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 416 | 345 | 352 | 369 | 367 |
Receivables | 1,080 | 1,078 | 1,010 | 1,135 | 1,225 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,611 | 1,638 | 1,735 | 1,690 | 1,690 |
Other Current Assets | 904 | 989 | 310 | 371 | 370 |
Total Current Assets | 4,011 | 4,050 | 3,407 | 3,565 | 3,652 |
Net Property & Equipment | 949 | 949 | 1,026 | 992 | 1,007 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 8,480 | 8,674 | 9,588 | 9,377 | 10,718 |
Deposits & Other Assets | 324 | 346 | 341 | 410 | 419 |
Total Assets | 13,764 | 14,019 | 14,362 | 14,344 | 15,796 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 291 | 302 | 270 | 296 | 354 |
Current Portion Long-Term Debt | 213 | 38 | 38 | 39 | 39 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 866 | 892 | 933 | 930 | 891 |
Total Current Liabilities | 1,370 | 1,232 | 1,241 | 1,265 | 1,284 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 524 | 530 | 567 | 643 | 658 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 5,463 | 5,727 | 5,736 | 5,870 | 6,023 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 465 | 595 | 432 | 411 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 7,822 | 7,963 | 8,139 | 8,210 | 8,376 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 8,790 | 8,777 | 8,777 | 8,763 | 8,752 |
Retained Earnings | -2,306 | -2,256 | -2,288 | -2,147 | -1,051 |
Other Equity | -542 | -465 | -266 | -482 | -281 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 5,942 | 6,056 | 6,223 | 6,134 | 7,420 |
Total Liabilities & Shareholder's Equity | 13,764 | 14,019 | 14,362 | 14,344 | 15,796 |
Total Common Equity | 5,942 | 6,056 | 6,223 | 6,134 | 7,420 |
Shares Outstanding | 494.10 | 494.10 | 492.80 | 492.60 | 492.50 |
Book Value Per Share | 12.03 | 12.26 | 12.63 | 12.45 | 15.07 |